^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells

    Associations
    News
    Trials
    Company:
    National Cancer Institute
    Drug class:
    CD3 inhibitor
    Related drugs:
    Associations
    News
    Trials